130 related articles for article (PubMed ID: 16717456)
1. A 17q21.31 microdeletion encompassing the MAPT gene in a mentally impaired patient.
Varela MC; Krepischi-Santos AC; Paz JA; Knijnenburg J; Szuhai K; Rosenberg C; Koiffmann CP
Cytogenet Genome Res; 2006; 114(1):89-92. PubMed ID: 16717456
[TBL] [Abstract][Full Text] [Related]
2. Microdeletion and microduplication 17q21.31 plus an additional CNV, in patients with intellectual disability, identified by array-CGH.
Kitsiou-Tzeli S; Frysira H; Giannikou K; Syrmou A; Kosma K; Kakourou G; Leze E; Sofocleous C; Kanavakis E; Tzetis M
Gene; 2012 Jan; 492(1):319-24. PubMed ID: 22037486
[TBL] [Abstract][Full Text] [Related]
3. Phenotypic expansion and further characterisation of the 17q21.31 microdeletion syndrome.
Tan TY; Aftimos S; Worgan L; Susman R; Wilson M; Ghedia S; Kirk EP; Love D; Ronan A; Darmanian A; Slavotinek A; Hogue J; Moeschler JB; Ozmore J; Widmer R; Bruno D; Savarirayan R; Peters G
J Med Genet; 2009 Jul; 46(7):480-9. PubMed ID: 19447831
[TBL] [Abstract][Full Text] [Related]
4. Identification of a patient with intellectual disability and de novo 3.7 Mb deletion supports the existence of a novel microdeletion syndrome in 2p14-p15.
Hancarova M; Vejvalkova S; Trkova M; Drabova J; Dleskova A; Vlckova M; Sedlacek Z
Gene; 2013 Mar; 516(1):158-61. PubMed ID: 23266801
[TBL] [Abstract][Full Text] [Related]
5. 17q21.31 microdeletion associated with infantile spasms.
Wray CD
Eur J Med Genet; 2013 Jan; 56(1):59-61. PubMed ID: 23123321
[TBL] [Abstract][Full Text] [Related]
6. A novel de novo 1.8 Mb microdeletion of 17q21.33 associated with intellectual disability and dysmorphic features.
Preiksaitiene E; Männik K; Dirse V; Utkus A; Ciuladaite Z; Kasnauskiene J; Kurg A; Kučinskas V
Eur J Med Genet; 2012 Nov; 55(11):656-9. PubMed ID: 22842074
[TBL] [Abstract][Full Text] [Related]
7. Clinical and molecular characterization of 17q21.31 microdeletion syndrome in 14 French patients with mental retardation.
Dubourg C; Sanlaville D; Doco-Fenzy M; Le Caignec C; Missirian C; Jaillard S; Schluth-Bolard C; Landais E; Boute O; Philip N; Toutain A; David A; Edery P; Moncla A; Martin-Coignard D; Vincent-Delorme C; Mortemousque I; Duban-Bedu B; Drunat S; Beri M; Mosser J; Odent S; David V; Andrieux J
Eur J Med Genet; 2011; 54(2):144-51. PubMed ID: 21094706
[TBL] [Abstract][Full Text] [Related]
8. Deletion of the RMGA and CHD2 genes in a child with epilepsy and mental deficiency.
Capelli LP; Krepischi AC; Gurgel-Giannetti J; Mendes MF; Rodrigues T; Varela MC; Koiffmann CP; Rosenberg C
Eur J Med Genet; 2012 Feb; 55(2):132-4. PubMed ID: 22178256
[TBL] [Abstract][Full Text] [Related]
9. A 17q21.31 microduplication, reciprocal to the newly described 17q21.31 microdeletion, in a girl with severe psychomotor developmental delay and dysmorphic craniofacial features.
Kirchhoff M; Bisgaard AM; Duno M; Hansen FJ; Schwartz M
Eur J Med Genet; 2007; 50(4):256-63. PubMed ID: 17576104
[TBL] [Abstract][Full Text] [Related]
10. Variable phenotype in 17q12 microdeletions: clinical and molecular characterization of a new case.
Palumbo P; Antona V; Palumbo O; Piccione M; Nardello R; Fontana A; Carella M; Corsello G
Gene; 2014 Apr; 538(2):373-8. PubMed ID: 24487052
[TBL] [Abstract][Full Text] [Related]
11. Detection of a novel familial deletion of four genes between BP1 and BP2 of the Prader-Willi/Angelman syndrome critical region by oligo-array CGH in a child with neurological disorder and speech impairment.
Murthy SK; Nygren AO; El Shakankiry HM; Schouten JP; Al Khayat AI; Ridha A; Al Ali MT
Cytogenet Genome Res; 2007; 116(1-2):135-40. PubMed ID: 17268193
[TBL] [Abstract][Full Text] [Related]
12. A further contribution to the delineation of the 17q21.31 microdeletion syndrome: central nervous involvement in two Italian patients.
Terrone G; D'Amico A; Imperati F; Carella M; Palumbo O; Gentile M; Canani RB; Melis D; Romano A; Parente I; Riccitelli M; Del Giudice E
Eur J Med Genet; 2012; 55(8-9):466-71. PubMed ID: 22659270
[TBL] [Abstract][Full Text] [Related]
13. De novo triplication of the MAPT gene from the recurrent 17q21.31 microdeletion region in a patient with moderate intellectual disability and various minor anomalies.
Gregor A; Krumbiegel M; Kraus C; Reis A; Zweier C
Am J Med Genet A; 2012 Jul; 158A(7):1765-70. PubMed ID: 22678764
[TBL] [Abstract][Full Text] [Related]
14. What can we learn from old microdeletion syndromes using array-CGH screening?
Mosca-Boidron AL; Bouquillon S; Faivre L; Callier P; Andrieux J; Marle N; Bonnet C; Vincent-Delorme C; Berri M; Plessis G; Manouvrier-Hanu S; Dieux-Coeslier A; Thauvin-Robinet C; Pipiras E; Delahaye A; Payet M; Ragon C; Masurel-Paulet A; Questiaux E; Benzacken B; Jonveaux P; Mugneret F; Holder-Espinasse M
Clin Genet; 2012 Jul; 82(1):41-7. PubMed ID: 21722100
[TBL] [Abstract][Full Text] [Related]
15. KANSL1 gene disruption associated with the full clinical spectrum of 17q21.31 microdeletion syndrome.
Moreno-Igoa M; Hernández-Charro B; Bengoa-Alonso A; Pérez-Juana-del-Casal A; Romero-Ibarra C; Nieva-Echebarria B; Ramos-Arroyo MA
BMC Med Genet; 2015 Aug; 16():68. PubMed ID: 26293599
[TBL] [Abstract][Full Text] [Related]
16. TWO CASES WITH DIFFERENT EPILEPSY TYPE AND DYSMORPHIC FEATURES ASSOCIATED WITH 17q21.31 MICRODELETION SYNDROME.
Uctepe E; Aktas D; Alikasifoglu M; Gunduz E; Sonmez FM
Genet Couns; 2016; 27(3):357-365. PubMed ID: 30204964
[TBL] [Abstract][Full Text] [Related]
17. 17q21.31 microdeletion: brain anomalies leading to prenatal diagnosis.
Egloff M; Encha-Razavi F; Garel C; Bonnière-Darcy M; Millischer AE; Lapierre JM; Fontaine S; de Blois MC; Vekemans M; Turleau C; Ville Y; Malan V
Cytogenet Genome Res; 2014; 144(3):178-82. PubMed ID: 25402493
[TBL] [Abstract][Full Text] [Related]
18. Clinical and molecular delineation of the 17q21.31 microdeletion syndrome.
Koolen DA; Sharp AJ; Hurst JA; Firth HV; Knight SJ; Goldenberg A; Saugier-Veber P; Pfundt R; Vissers LE; Destrée A; Grisart B; Rooms L; Van der Aa N; Field M; Hackett A; Bell K; Nowaczyk MJ; Mancini GM; Poddighe PJ; Schwartz CE; Rossi E; De Gregori M; Antonacci-Fulton LL; McLellan MD; Garrett JM; Wiechert MA; Miner TL; Crosby S; Ciccone R; Willatt L; Rauch A; Zenker M; Aradhya S; Manning MA; Strom TM; Wagenstaller J; Krepischi-Santos AC; Vianna-Morgante AM; Rosenberg C; Price SM; Stewart H; Shaw-Smith C; Brunner HG; Wilkie AO; Veltman JA; Zuffardi O; Eichler EE; de Vries BB
J Med Genet; 2008 Nov; 45(11):710-20. PubMed ID: 18628315
[TBL] [Abstract][Full Text] [Related]
19. Deletion at chromosome 10p11.23-p12.1 defines characteristic phenotypes with marked midface retrusion.
Okamoto N; Hayashi S; Masui A; Kosaki R; Oguri I; Hasegawa T; Imoto I; Makita Y; Hata A; Moriyama K; Inazawa J
J Hum Genet; 2012 Mar; 57(3):191-6. PubMed ID: 22258158
[TBL] [Abstract][Full Text] [Related]
20. Hypersociability in the behavioral phenotype of 17q21.31 microdeletion syndrome.
Egger JI; Wingbermühle E; Verhoeven WM; Dijkman M; Radke S; de Bruijn ER; de Vries B; Kessels RP; Koolen D
Am J Med Genet A; 2013 Jan; 161A(1):21-6. PubMed ID: 23169757
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
